Related Experiment Video
Updated: Jun 1, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Cancer survival in the Gambia, 1993-1997
1National Cancer Registry, The Gambia, c/o IARC-Gambia Hepatitis Intervention Study, MRC Laboratories, Fajara, Banjul, The Gambia. ebah@iarc.fr
Cancer survival rates in The Gambia are low, with 5-year survival for common cancers like cervix and breast cancer below 25%. This highlights critical needs for improved cancer diagnosis and treatment strategies in the region.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- The Gambia established its national cancer registry in 1986.
- Cancer registration utilizes active and passive methods.
- Collaborations include IARC, France; UK Medical Research Council (MRC); and the Gambian Government.
Purpose of the Study:
- To analyze cancer survival data from The Gambia.
- To report 5-year relative survival rates for selected cancers.
- To investigate survival patterns across different age groups.
Main Methods:
- Utilized data from the national cancer registry (1993-1997).
- Employed predominantly active follow-up methods (median 1-6 months).
- Included 54-82% of registered cases for survival analysis; histological verification ranged from 1-45%.
Main Results:
- Five-year age-standardized relative survival: Cervix (23%), Non-Hodgkin lymphoma (22%), Breast (10%), Stomach (4%), Liver (3%).
- Complete 5-year follow-up ranged from 81-98% for various cancers.
- Survival by age group showed fluctuations with no clear trend and few survivors in many intervals.
Conclusions:
- The study reveals critically low 5-year survival rates for major cancers in The Gambia.
- Survival data indicates significant challenges in cancer management and outcomes.
- Further research and interventions are needed to improve cancer survival in the region.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
Cancer Prevention
Some...
Cancer Prevention
Some...
Treatment Resistent Cancers
Cancer
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

